Preclinical gene therapy for glaucoma: single intracameral injection encoding tPA that restores trabecular meshwork outflow and normalizes intraocular pressure for glaucoma patients. Disease‑modifying, gene‑agnostic approach with durable IOP lowering shown in mouse and sheep models and currently in IND‑enabling/toxicology studies.